Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Yüksel, Gümürdülü"'
Autor:
Ümit Karaoğullarından, Yüksel Gümürdülü, Oğuz Üsküdar, Emre Odabaş, Hasan Selim Güler, Cansu Geçkalan, Burcu Aslan Benli, Anıl Delik, Asena Ayça Özdemir, Sedef Kuran
Publikováno v:
The Turkish Journal of Gastroenterology, Vol 35, Iss 3, Pp 204-211 (2024)
Background/Aims: Hepatocellular carcinoma is a major cause of mortality and morbidity in both cirrhotic and non-cirrhotic patients, and most patients are suitable for locoregional and/or systemic therapy at the time of diagnosis. In this study, we ai
Externí odkaz:
https://doaj.org/article/8ab6a9be41344fd595e287bb50f622d7
Autor:
Ümit, Karaoğullarindan, Yüksel, Gümürdülü, Oguz, Üsküdar, Emre, Odabaş, Hasan Selim, Güler, Nur, Tozluklu, Emine, Bağir, Sedef, Kuran
Publikováno v:
European Journal of Gastroenterology & Hepatology. 35:89-93
Hepatocellular carcinoma (HCC) is the seventh most common cancer all worldwide and is second in cancer-related deaths. In HCC, whose prognosis is still not good despite current treatments, there is a need for prognostic markers as well as early diagn
Autor:
Ümit, Karaoğullarindan, Yüksel, Gümürdülü, Oguz, Üsküdar, Emre, Odabaş, Hasan Selim, Güler, Anil, Delik, Sedef, Kuran
Publikováno v:
European Journal of Gastroenterology & Hepatology. 34:956-960
Hepatocellular carcinoma (HCC) is a cancer with a poor prognosis, its incidence increases with age. The risk of developing HCC is highest in the seventh decade. In this study, we aimed to determine the clinicopathological differences, treatment choic
Autor:
Ümit Karaoğullarindan, Oguz Üsküdar, Emre Odabaş, Melike Saday, Gamze Akkuş, Anil Delik, Yüksel Gümürdülü, Sedef Kuran
Publikováno v:
Indian Journal of Gastroenterology.
Autor:
Ümit Karaogullarindan, Oguz Uskudar, Emre Odabas, Nur Tozluklu, Hasan Selim Güler, Sedef Kuran, Burcu Arslan Benli, Yüksel Gümürdülü
Purpose: Hepatocellular carcinoma (HCC) is the seventh most common cancer all over the world and is second in cancer-related deaths. . In HCC, whose prognosis is still not good despite current treatments, there is a need for prognostic markers as wel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb4988ae97c9a44030274ed4b4817c51
https://doi.org/10.21203/rs.3.rs-1375407/v1
https://doi.org/10.21203/rs.3.rs-1375407/v1
Publikováno v:
Annals of Hepatology, Vol 11, Iss 4, Pp 513-518 (2012)
Introduction. The use of prognostic models for cirrhotic patients admitted to the medical intensive care unit (ICU) is of great importance, since they provide an objective evaluation for a group of patients with high mortality rates and high resource
Externí odkaz:
https://doaj.org/article/cd23d09ff54c4de1b7e6f96a1737c3c7
Publikováno v:
Turk J Gastroenterol
Background Reactivation of Hepatitis B (HBVr) related to immunosuppressive drug therapy (ISDT) in patients with resolved and past infection is a challenging entity. The number of prospective long-term studies is limited. Methods Two groups of patient
Autor:
Ahmet Güzel, Yüksel Gümürdülü, Didem Arslan Tas, Ümit Karaoğullarından, Salih Tokmak, Ghanim Khatib, I. Oguz Kara
Publikováno v:
SSRN Electronic Journal.
Background: Hepatitis B virus reactivation (HBVr) during immunosuppressive drug therapy (ISDT) is a growing concern; however, prospective long-term follow-up studies are rare. Methods: In this cross-sectional study, we analyzed two groups of patients
Publikováno v:
The Turkish Journal of Gastroenterology. 24:387-391
PubMedID: 24557961 Background/aims: The BioEnterics intragastric balloon has been considered an effective and less invasive method for weight loss. This study aimed to evaluate the effect of this method on long-term weight loss. Material and Methods:
Publikováno v:
The Turkish Journal of Gastroenterology. 23:247-252
Background/aims Chronic hepatitis B virus infection is an important cause of morbidity and mortality. Tenofovir disoproxil fumarate and entecavir were licensed for the treatment of hepatitis B virus infection. We evaluated the first 12 months of chro